Inhibitory Effect of Berbamine on Proliferation of Retinoblastoma HXO-RB_(44) Cells
Yan Li
Abstract
Yan Li
Abstract
Objective: To investigate the effect of berbamine (BBM) on the proliferation and cell cycle of retinoblastoma HXO-RB44 cells. Methods: HXO-RB44 cells were cultured in vitro. The inhibitory effect of BBM on the cell proliferation was assayed by MTT method after being interfered for 24 h, 48 h and 72 h by 0, 2, 4, 8, 16 and 32 mg/L, respectively. The cell cycles were analyzed by flow cytometry (FCM) after being interfered 24 h by 0, 4, 8 and 16 mg/L BBM, respectively. Results: The cell proliferation was significantly inhibited by BBM in a dose-dependent manner (P 0.05). Values of IC50 were 25.26, 10.94 and 6.25 mg/L for 24 h, 48 h and 72 h after treatment , respectively. The result of FCM analysis showed that BBM significantly inhibited the cell cycle, and increased the number of cells in G2/M phase compared with those of control group (P 0.01). Conclusion: Berbamine can inhibit the proliferation of HXO-RB44 cells and induce cell cycle arrest in G2/M phase, which suggests that BBM may be an effective anti- retinoblastoma drug.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the effect of berbamine (BBM) on the proliferation and cell cycle of retinoblastoma HXO-RB44 cells. Methods: HXO-RB44 cells were cultured in vitro. The inhibitory effect of BBM on the cell proliferation was assayed by MTT method after being interfered for 24 h, 48 h and 72 h by 0, 2, 4, 8, 16 and 32 mg/L, respectively. The cell cycles were analyzed by flow cytometry (FCM) after being interfered 24 h by 0, 4, 8 and 16 mg/L BBM, respectively. Results: The cell proliferation was significantly inhibited by BBM in a dose-dependent manner (P 0.05). Values of IC50 were 25.26, 10.94 and 6.25 mg/L for 24 h, 48 h and 72 h after treatment , respectively. The result of FCM analysis showed that BBM significantly inhibited the cell cycle, and increased the number of cells in G2/M phase compared with those of control group (P 0.01). Conclusion: Berbamine can inhibit the proliferation of HXO-RB44 cells and induce cell cycle arrest in G2/M phase, which suggests that BBM may be an effective anti- retinoblastoma drug.
Key concepts: Cell cycle, Flow cytometry, Cell growth, Retinoblastoma, Molecular biology, Chemistry, Cell, Retinoblastoma protein